Purecycle Technologies Earnings Call Transcript Summary of Q1 2026
Key investor takeaways from PureCycle's Q1 2026 update:
- Operational progress: Ironton produced 8.4 million pounds of PureFive in Q1 (up 12% vs Q4) and processed ~10 million pounds of feedstock. A planned full plant turnaround was completed ahead of schedule and ~15% below budget; the outage executed 170+ improvement projects focused on capacity, reliability and quality. On-site compounding reached mechanical completion in April and is being commissioned; third-party compounding volumes ramped to ~1.7 million pounds in Q1.
- Commercial momentum: Q1 revenue was $4.1 million (fifth consecutive quarter of sequential growth) with a meaningful increase in branded sales. The company achieved commercial qualifications with Procter & Gamble (Tide caps shipping in Q2; Vicks ZzzQuil caps in H2 2026) and converted multiple new customers (including Plastic Ingenuity for coffee lids). Pipeline expanded to ~180 active opportunities. Management expects multiple branded application ramps across 2026 (40–50M lbs beginning Q2–Q3, plus an additional 20–25M lbs starting Q3–Q4), with significant demand contingent on regulatory developments (notably New Jersey).
- Regulatory & macro tailwinds: Rising virgin PP and HDPE prices, petrochemical supply disruptions, and tightening regulations (California SB 54 source-reduction targets and New Jersey recycled-content increases/food-contact rule changes) create near-term urgency and pricing tailwinds. PureCycle highlights APR certification and CosPaTox highest-purity validation as competitive differentiators for food- and cosmetic-grade applications.
- Growth projects and capital plan: Thailand plant targeted for mechanical completion end-2027 and operational commissioning Q1 2028 (total investment ~ $250M; construction to break ground H2 2026). Belgium facility remains on track for permitting late 2026 and mechanical completion by end-2028 (~€350M investment); PureCycle secured a €40M European Innovation Fund grant for Belgium. Gen 2 economics are validating and advanced design work is underway.
- Financials & liquidity: Q1 net loss was $33.4M; adjusted EBITDA was negative $30.9M (includes ~$7M of project development costs expensed). Production grew ~95% YoY while monthly operations spending increased only ~6% (operational leverage). Total liquidity ended Q1 at ~$131M (cash $90M, marketable securities ~$31M, restricted cash $10M). Project spend was ~$14M in Q1 (below prior quarterly expectation); FY2026 project spend guide remains $39M–$45M. Company extended warrants to March 17, 2027 (now ~$273M potential proceeds) and has an undrawn $200M revolving credit facility and ~$75M of revenue bonds available. SOPA bond debt service (~$9M) is due June 1, with flexibility to monetize SOPA holdings to offset the payment.
- Outlook: Management reiterates confidence in the 2026 ramp, expects commercial volumes to meaningfully increase in H2 2026, and emphasizes that regulatory deadlines (especially New Jersey and California) are driving urgency among brands. They are not providing formal revenue guidance at this time but assert internal plans for 2026 are achievable.